BeStock  
Stocks › SNDX

Syndax Pharmaceuticals SNDX

US equityMarket cap rank #2936
$17.83 +$0.23 (+1.31%)
Pre-market · Oct 6, 5:40 am ET · After hours $17.83 0.00%
Open$17.58
Prev close$17.60
Day range$17.57 – $17.98
Volume1.46M
Market cap$1.59B
P/E (TTM)–
Dividend yield–

Cash flow

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Operating Cash Flow -$322.98M -$274.90M -$160.60M -$133.68M $29.13M
Net cash flow from continuing operations -$322.98M -$274.90M -$160.60M -$133.68M $29.13M
Net Income from Continuing Operations -$285.42M -$318.76M -$209.36M -$149.34M $24.93M
Depreciation & Depletion & Amortization $6,000.00 $8,000.00 $12,000.00 $33,000.00 $43,000.00
Other Non-Cash Items $1.34M $1.02M $739,000.00 $1.52M $187,000.00
Change in Working Capital -$79.32M $13.27M $31.86M $1.66M -$9.60M
-Change in Receivables -$79.81M $762,000.00 $10.71M $0.00 –
-Change in Inventory -$32.09M -$366,000.00 $0.00 $0.00 –
-Change in Prepaid Assets -$14.54M -$8.39M $676,000.00 -$2.97M -$1.39M
-Change in Payables and Accrued Expense $47.12M $20.80M $20.48M $8.10M $4.93M
-Change in Other Current Assets $0.00 $463,000.00 $0.00 $0.00 –
Net cash flow from investing $290.04M -$219.78M $117.61M -$186.19M -$40.87M
Net Cash Flow from Continuing Investing Activities $290.04M -$219.78M $117.61M -$186.19M -$40.87M
Net PPE Purchase and Sale -$187,000.00 $0.00 $0.00 $225,000.00 -$129,000.00
Net Investment Purchase and Sale $290.22M -$219.78M $117.61M -$186.41M -$40.74M
Financing Cash Flow $13.68M $353.37M $264.13M $172.25M $118.46M
Net Cash Flow from Continuing Financing Activities $13.68M $353.37M $264.13M $172.25M $118.46M
Net Common Stock Issuance $0.00 $0.00 $258.09M $181.39M $86.34M
Proceeds from Stock Option Exercised $13.68M $9.72M $6.04M $11.86M $31.55M
Ending Cash Balance $135.03M $154.30M $295.61M $74.47M $222.08M
Net Change in Cash -$19.27M -$141.31M $221.14M -$147.61M $106.72M
Beginning Cash Balance $154.30M $295.61M $74.47M $222.08M $115.36M
Free Cash Flow -$323.17M -$274.90M -$160.60M -$133.68M $29.00M
Net Other Financing Charges – $343.65M – – $576,000.00
Gain/Loss from Continuing Operations – – – -$187,000.00 -$389,000.00
-Change In Other Working Capital – – – -$3.47M -$13.13M
Net Issuance Payments Of Debt – – – -$21.00M $0.00

Discussion

No comments yet — be the first to weigh in on SNDX.

Leave a comment

Scroll to Top